Inventor profile of:

Wolfgang Eisert

City:

Hannover

Country:

Germany

Published Applications:

14

Last publication date:

2009-12-31

Top Assignees for applications by Wolfgang Eisert

The entities that hold a legal rights for patent applications filed by inventor Eisert Wolfgang:

Recent patent applications by Eisert Wolfgang

Wolfgang Eisert from Hannover, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2009-12-31
US20090326633A1
Human necessities

CONTROLLED RELEASE ENDOPROSTHETIC DEVICE

#2 | 2009-07-30
US20090192123A1
Human necessities

Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of Thrombin and/or by elevated expression of Thrombin receptors

#3 | 2009-03-19
US20090075949A1
Human necessities

Use of dipyridamole in combination with antithrombotics for treatment and prevention of thromboembolic diseases

#4 | 2009-02-19
US20090048173A1
Human necessities

Use Of Dipyridamole For Treatment Of Resistance To Platelet Inhibitors

#5 | 2008-05-15
US20080113934A1
Human necessities

USE OF DIPYRIDAMOLE OR MOPIDAMOL FOR TREATMENT AND PREVENTION OF FIBRIN-DEPENDENT MICROCIRCULATION DISORDERS

#6 | 2008-04-03
US20080082156A1
Human necessities

CONTROLLED RELEASE ENDOPROSTHETIC DEVICE

#7 | 2008-03-27
US20080076786A1
Human necessities

USE OF RADICAL-SCAVENGING COMPOUNDS FOR TREATMENT AND PREVENTION OF NO-DEPENDENT MICROCIRCULATION DISORDERS

#8 | 2007-05-10
US20070105753A1
Human necessities

USE OF DIPYRIDAMOLE OR MOPIDAMOLE FOR TREATMENT AND PREVENTION OF THROMBO-EMBOLIC DISEASES AND DISORDERS CAUSED BY EXCESSIVE FORMATION OF THROMBIN AND/OR BY ELEVATED EXPRESSION OF THROMBIN RECEPTORS

#9 | 2007-04-12
US20070082917A1
Human necessities

Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders

#10 | 2006-06-20
US10121496
-

Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders

#11 | 2006-06-15
US20060128730A1
Human necessities

Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders

#12 | 2005-12-22
US20050282830A1
Human necessities

Use of dipyridamole or mopidamole for treatment and prevention of MMP-9-dependent disorders

#13 | 2005-09-01
US20050192664A1
Human necessities

Controlled release endoprosthetic device

#14 | 2005-01-20
US20050014770A1
Human necessities

Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors

InventorID:

3884145 ⎘